Trials / Completed
CompletedNCT04074434
Study Watch Atrial Fibrillation (AF) Detection Investigation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (actual)
- Sponsor
- Verily Life Sciences LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, non-randomized study to refine the Study Watch's algorithm for AF detection within both persistent and paroxysmal AF subjects. The study will also collect data from an FDA-cleared wearable ECG sensor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Study Watch | Study Watch is a miniaturized physiological data monitoring and data collection device for continuous recording of physiological and environmental data |
Timeline
- Start date
- 2018-11-12
- Primary completion
- 2019-07-17
- Completion
- 2019-07-22
- First posted
- 2019-08-30
- Last updated
- 2019-09-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04074434. Inclusion in this directory is not an endorsement.